[EMERGINCaRE, the horizon scanning system for anticancer drugs of the French National Cancer Institute].

Duperray M, Bertin C, Sagot L, Breton T, Ifrah N

DOI: 10.1016/j.bulcan.2024.04.007
Published: 2024 Sep
Container: Bulletin du cancer
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.bulcan.2024.04.007,
  title = {[EMERGINCaRE, the horizon scanning system for anticancer drugs of the French National Cancer Institute].},
  author = {Duperray M and Bertin C and Sagot L and Breton T and Ifrah N},
  year = {2024},
  journal = {Bulletin du cancer},
  doi = {10.1016/j.bulcan.2024.04.007},
  url = {https://doi.org/10.1016/j.bulcan.2024.04.007}
}

RIS

TY  - JOUR
TI  - [EMERGINCaRE, the horizon scanning system for anticancer drugs of the French National Cancer Institute].
AU  - Duperray M
AU  - Bertin C
AU  - Sagot L
AU  - Breton T
AU  - Ifrah N
PY  - 2024
JO  - Bulletin du cancer
DO  - 10.1016/j.bulcan.2024.04.007
UR  - https://doi.org/10.1016/j.bulcan.2024.04.007
ER  -

APA

M, D., C, B., L, S., T, B., & N, I. (2024). [EMERGINCaRE, the horizon scanning system for anticancer drugs of the French National Cancer Institute].. Bulletin du cancer. https://doi.org/10.1016/j.bulcan.2024.04.007

Source records

pubmed · retrieved 2026-09-25T23:29:44.440Z